Summary
Ten patients with advanced cancer were treated in a phase-1 trial with monthly cycles of a 5-day infusion of vinblastine. Serum drug levels were relatively constant after 24 h and there was no correlation between drug level and myelo-suppression or toxicity. Previously underscribed toxicities were observed, including one hypersensitivity reaction and three cases of severe, only slowly reversible, sensorimotor neuropathy. Two patients showed objective tumor regression during the vinblastine infusion therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bodey CP, Yap H-Y, Yap B-S, Valdivieso M (1980) Continuous-infusion vindesine in solid tumors. Cancer Treat Rev [Suppl] 7: 39
Chirife AM, Studzinski GP (1978) Definition of the cell cycle segment with special sensitivity to vinblastine. Proc Soc Exp Biol Med 157: 206
Hande K, Gay J, Gober J Greco FA (1980) Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion. Cancer Treat Rev [Suppl] 7: 25
Jackson DV, Sethi VS, Spurr CL, et al. (1981) Intravenous vincristine infusion: phase I trial. Cancer 48: 2559
Nelson RL, Dyke RW, Root MA (1980) Comparative pharmacokinetics of vindesine, vincristine, and vinblastine in patients with cancer. Cancer Treat Rev [Suppl] 7: 17
Owellen RJ, Hartke CA, Hains FO (1977) Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res 37: 2597
Schulman P, Budman DR, Vinciguerra V, Degman TJ (1980) Phase I evaluation of divided-dose vinblastine sulfate. Cancer Chemother Pharmacol 5: 67
Sethi VS, Burton SS, Jackson DV (1980) A sensitive radioimmunoassay for vincristine and vinblastine. Cancer Chemother Pharmacol 4: 183
Thant M, Hawley RT, Smith MT, et al (1982) Possible enchancement of vincristine neuropathy by VP-16. Cancer 49: 859
Yap H-Y, Blumenschein GR, Keating MJ, et al (1980) Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep 64: 279
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, J.A., Howell, S.B. & Green, M.R. Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine. Cancer Chemother. Pharmacol. 12, 43–45 (1984). https://doi.org/10.1007/BF00255908
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00255908